当前位置: X-MOL 学术J. Bone Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Long non-coding RNA KRT8P41/miR-193a-3p/FUBP1 axis modulates the proliferation and invasion of chordoma cells
Journal of Bone Oncology ( IF 3.1 ) Pub Date : 2021-09-27 , DOI: 10.1016/j.jbo.2021.100392
Hai Wen 1 , Yang Fu 1 , Yapeng Zhu 1 , Siyue Tao 1 , Xifu Shang 2 , Zhongqi Li 1 , Tao You 1 , Wenzhi Zhang 1
Affiliation  

Chordomas are low-grade malignancies accounting for 1–4% of primary bone malignancies. Moreover, local recurrences increase the rate of metastasis. Our previous study identified the far upstream element (FUSE)-binding protein 1 (FUBP1) as a biomarker and potential therapeutic target for chordoma. In this study, lncRNA KRT8P41 was identified as a lncRNA positively correlated with FUBP1. In chordoma patients, higher lncRNA KRT8P41 expression was correlated with a poorer prognosis. LncRNA KRT8P41 silencing significantly inhibited chordoma cell proliferation and invasion. miR-193a was negatively correlated with lncRNA KRT8P41 and FUBP1; lncRNA KRT8P41 inhibited miR-193a expression, and miR-193a inhibited FUBP1 expression. Furthermore, miR-193a directly bound to lncRNA KRT8P41 and FUBP1 and lncRNA KRT8P41 competed with FUBP1 for miR-193a binding and relieved miR-193a-mediated FUBP1 inhibition. LncRNA KRT8P41 silencing inhibited, whereas miR-193a inhibition promoted chordoma cell proliferation and invasion; the inhibition of miR-193a attenuated the roles of lncRNA KRT8P41. Within chordoma tissues, the expression of miR-193a was decreased, and the expression of FUBP1 increased compared to normal control tissues. LncRNA KRT8P41 exhibited a positive correlation with FUBP1 and a negative correlation with miR-193a in vivo. Therefore, it was concluded that lncRNA KRT8P41, miR-193a-3p, and FUBP1 form a lncRNA-miRNA-mRNA axis, modulating the proliferation and invasion of chordoma cells.



中文翻译:

长链非编码 RNA KRT8P41/miR-193a-3p/FUBP1 轴调节脊索瘤细胞的增殖和侵袭

脊索瘤是低度恶性肿瘤,占原发性骨恶性肿瘤的 1-4%。此外,局部复发会增加转移率。我们之前的研究将远上游元件 (FUSE) 结合蛋白 1 (FUBP1) 确定为脊索瘤的生物标志物和潜在治疗靶点。在本研究中,lncRNA KRT8P41 被鉴定为与 FUBP1 正相关的 lncRNA。在脊索瘤患者中,较高的 lncRNA KRT8P41 表达与较差的预后相关。LncRNA KRT8P41 沉默显着抑制脊索瘤细胞增殖和侵袭。miR-193a与lncRNA KRT8P41和FUBP1呈负相关;lncRNA KRT8P41抑制miR-193a表达,miR-193a抑制FUBP1表达。此外,miR-193a 直接与 lncRNA KRT8P41 和 FUBP1 结合,lncRNA KRT8P41 与 FUBP1 竞争 miR-193a 结合并解除 miR-193a 介导的 FUBP1 抑制。LncRNA KRT8P41 沉默抑制,而 miR-193a 抑制促进脊索瘤细胞增殖和侵袭;miR-193a 的抑制减弱了 lncRNA KRT8P41 的作用。在脊索瘤组织中,与正常对照组织相比,miR-193a 的表达降低,FUBP1 的表达增加。LncRNA KRT8P41与FUBP1呈正相关,与miR-193a呈负相关 与正常对照组织相比,miR-193a的表达降低,FUBP1的表达增加。LncRNA KRT8P41与FUBP1呈正相关,与miR-193a呈负相关 与正常对照组织相比,miR-193a的表达降低,FUBP1的表达增加。LncRNA KRT8P41与FUBP1呈正相关,与miR-193a呈负相关体内。因此,推断lncRNA KRT8P41、miR-193a-3p和FUBP1形成lncRNA-miRNA-mRNA轴,调节脊索瘤细胞的增殖和侵袭。

更新日期:2021-10-19
down
wechat
bug